In a ‘shocker’ decision, Japan approves mpox drug that failed in two efficacy trials | Science
On 2 January, Japan’s regulatory agency issued a news release that startled some scientists: It had approved the antiviral drug tecovirimat, …Read More
The Heartbeat of World events
On 2 January, Japan’s regulatory agency issued a news release that startled some scientists: It had approved the antiviral drug tecovirimat, …Read More
